SCYX (SCYNEXIS) Shiller PE Ratio: (As of Sep. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SCYX SCYNEXIS Inc SCYX
34 GF Score
Price $4.60
GF Value $17.62
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is SCYNEXIS Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


SCYNEXIS  (NAS:SCYX) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


SCYNEXIS Shiller PE Ratio Related Terms


SCYNEXIS Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for SCYNEXIS's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SCYNEXIS Shiller PE Ratio Chart

SCYNEXIS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SCYNEXIS Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SCYX vs TLPH, IXHL, CPHI: Shiller PE Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, SCYNEXIS's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SCYNEXIS Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SCYNEXIS's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where SCYNEXIS's Shiller PE Ratio falls into.


SCYX
34GF Score
SCYNEXIS Inc SCYX
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SCYNEXIS Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

SCYNEXIS's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, SCYNEXIS's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.63/333.9520*333.9520
=0.630

Current CPI (Jun. 2026) = 333.9520.

SCYNEXIS Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 -38.400 241.428 -53.116
201612 -4.000 241.432 -5.533
201703 -20.000 243.801 -27.395
201706 -12.800 244.955 -17.450
201709 -24.800 246.819 -33.555
201712 -21.600 246.524 -29.260
201803 -9.600 249.554 -12.847
201806 -18.400 251.989 -24.385
201809 0.800 252.439 1.058
201812 4.800 251.233 6.380
201903 -36.800 254.202 -48.345
201906 -12.640 256.143 -16.480
201909 -11.600 256.759 -15.087
201912 -17.120 256.974 -22.248
202003 -5.760 258.115 -7.452
202006 -5.120 257.797 -6.632
202009 -2.240 260.280 -2.874
202012 -31.360 260.474 -40.206
202103 -1.840 264.877 -2.320
202106 -1.760 271.696 -2.163
202109 -0.480 274.310 -0.584
202112 -8.880 278.802 -10.637
202203 -1.440 287.504 -1.673
202206 -2.480 296.311 -2.795
202209 -4.960 296.808 -5.581
202212 -2.320 296.797 -2.610
202303 -5.680 301.836 -6.284
202306 19.680 305.109 21.540
202309 -0.320 307.789 -0.347
202312 -3.280 306.746 -3.571
202403 0.080 312.332 0.086
202406 -2.400 314.175 -2.551
202409 -0.480 315.301 -0.508
202412 -0.720 315.605 -0.762
202503 -0.880 319.799 -0.919
202506 -1.110 322.561 -1.149
202509 -1.360 324.800 -1.398
202512 2.000 324.054 2.061
202603 -3.360 330.213 -3.398
202606 0.630 333.952 0.630

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is SCYNEXIS (SCYX) Overvalued in 2026?

Based on GuruFocus' analysis, SCYNEXIS stock appears to be undervalued. The current stock price of $4.60 is trading 73.9% below its estimated GF Value™ of $17.62. GuruFocus considers SCYNEXIS to be Possible Value Trap.

Key valuation signals for SCYX:

  • Shiller PE Ratio:
  • GF Value™: $17.62 vs. price of $4.60 (73.9% below fair value)
  • GF Score™: 34/100 with 3 warning signs

No single metric tells the full story. See the SCYX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SCYNEXIS Business Description

Other Exchanges 0L49:UK135:Germany
Address 1 Evertrust Plaza, 13th Floor, Jersey City, NJ, USA, 07302 - 6548
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
34GF Score

Get the complete analysis for SCYX

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.60
Price
$17.62
GF Value